DermTech, Inc.
Healthcare · Services-Medical Laboratories · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $15.3M | $14.5M | $11.8M | $5.9M | $3.4M | $2.4M |
| Operating income | −$103.7M | −$118.2M | −$77.4M | −$35.3M | −$17.6M | −$8.6M |
| Net income | −$100.9M | −$116.7M | −$78.3M | −$36.5M | −$20.1M | −$10.0M |
| Total assets | $121.9M | $202.1M | $248.3M | $69.8M | $18.2M | $5.7M |
| Total liabilities | $64.8M | $69.7M | $18.6M | $7.9M | $6.3M | $11.0M |
| Equity | $57.2M | $132.4M | $229.7M | $61.8M | $11.9M | −$5.4M |
| EPS (diluted) | $-3.09 | $-3.88 | $-2.71 | — | — | — |
| Shares out. | 30.4M | 29.9M | 28.8M | 14.8M | 5.3M | 18.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −678.2%
- Net margin
- −659.6%
- Return on equity
- −176.5%
- Return on assets
- −82.7%
- Return on capital (ROCE)
- −95.6%
- Liabilities / assets
- 53.1%
- Debt / equity
- 1.13×
- Book value / share
- $1.88
- Revenue growth (YoY)
- 5.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -13.53distress
- Accruals / assets
- −19.6%clean
- Beneish M-Score
- -2.96normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 2, 2022
- NT 10-Qmissed a reporting deadline ↗Aug 12, 2019
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Sun Kevin MOfficer — Chief Financial Officer | Jun 10, 2024 | Tax withholding | 445 | $0.34 |
| Akhavan RaminOfficer — General Counsel | Jun 5, 2024 | Tax withholding | 1,757 | $0.31 |
| Sun Kevin MOfficer — Chief Financial Officer | Jun 5, 2024 | Tax withholding | 179 | $0.31 |
| Sun Kevin MOfficer — Chief Financial Officer | Mar 10, 2024 | Tax withholding | 445 | $0.70 |
| Akhavan RaminOfficer — General Counsel | Mar 5, 2024 | Tax withholding | 1,758 | $0.88 |
| Sun Kevin MOfficer — Chief Financial Officer | Mar 5, 2024 | Tax withholding | 180 | $0.88 |
| Akhavan RaminOfficer — General Counsel | Jan 5, 2024 | Tax withholding | 3,202 | $1.50 |
| Sun Kevin MOfficer — Chief Financial Officer | Dec 7, 2023 | Sell | 188 | $1.53 |
| Ibarra ClaudiaOfficer — Chief Operating Officer | Dec 7, 2023 | Sell | 143 | $1.53 |
| Akhavan RaminOfficer — General Counsel | Dec 7, 2023 | Sell | 1,768 | $1.53 |
| Aguillard Mark BryanOfficer — Chief Commercial Officer | Sep 20, 2023 | Grant | 90,000 | $0.00 |
| Sun Kevin MOfficer — Chief Financial Officer | Sep 8, 2023 | Sell | 223 | $1.93 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeJun 20, 2024
- Bankruptcy or receivership · Costs from exit or disposal · Director / officer change · Other material eventJun 18, 2024
- Debt acceleration / triggering event · Other material eventMay 17, 2024
- Results of operationsMay 14, 2024
- Debt acceleration / triggering eventMay 10, 2024
- Costs from exit or disposal · Other material eventApr 18, 2024
- Delisting / listing-standard noticeApr 16, 2024
- Results of operationsFeb 29, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.